Study of lipid profile, serum magnesium and blood glucose in hypertension

Biology and Medicine

Volumn 2, Issue 1, 2010, Pages 6-16

  Lakshmana Kumar, N ^a   Deepthi, J ^a   Rao, Y N ^a   Kiran Deedi, M ^a  

^a GSL Medical College   (India)

Author keywords

Dyslipidemia; Hypertension; Serum magnesium

Indexed keywords

EID: 78650537142     PISSN: None     EISSN: 09748369     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chalmers J, Omae T, Gyarfas I, 1999. Guidelines Sub-Committee, World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Journal of Hypertension, 17(2): 151-183.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo, JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, 2003. Seventh report of the joint national committee on prevention, detection, Evaluation and treatment of high blood pressure. Hypertension, 42: 1206-52.
3. Chockalingam A, Campbell NR, Fodor JG, 2006. Worldwide epidemic of hypertension. Canadian Journal of Cardiology, 22(7): 553-555.
4. Foosati P, Prencipe L, 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry, 28: 2077-2080.
5. Franklin SS, Larson MG, Kahn SA, Wong ND, Leip EP, Kannel WB, Levy D, 2001. Does the relation of Blood Pressure to Coronary Heart Disease risk change with ageing? The Framingham Heart Study. Circulation, 103: 1245-1249.
6. Giles TD, Berk BC, Black HR, Cohn JN, Kostis JB, Izzo JL, Weber MA, 2005. Expanding the Definition and Classification of Hypertension. Journal of Clinical Hypertension, 7(9): 505-512.
7. Gindler EM, Heth DA, 1971. Colorimetric determination with bound calmagite of magnesium in human blood serum. Clinical Chemistry, 17: 662.
8. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J, 2005. Global burden of hyper tension: Analysis of worldwide data. Lancet, 365(9455): 217-223.
9. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC, 2007. Relationship between Gamma Glutamyl Transferase, Lipids and Lipoprotein (a) in general population. Clinica Chimica Acta, 384(1-2): 163-166.
10. Moncia G, Guy DB, Anna D, Renata C, Robert F, Giuseppe G, Guido G, Anthony MH, Sverre EK, Stephane L, Krzysztof N, Luis R, Andrzej, R, Roland ES, Struijker HAJ, Alberto Z, 2007. Guidelines for the management of Arterial Hypertension: The task force for the management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 25(6): 1105-1187.
11. Richmond W, 1973. Preparation and Properties of a Cholesterol Oxidase from Nocardia species and its application to the enzymatic assay of Total Cholesterol in serum. Clinical Chemistry, 19: 1350-1356.
12. Sanders GT, Huijgen HJ, Sanders R, 1999. Magnesium in disease: A review with special emphasis on the serum ionized magnesium. Clinical chemistry and Laboratory Medicine, 37(11-12): 1011-1033.
13. Sellers EAC, Yung G, Dean HJ, 2007. Dyslipidemia and other cardiovascular risk factor in a Canadian first nation pediatric population with type 2 diabetes Mellitus. Pediatric Diabetes, 8(6): 384-390.
14. Shugeri LS, Xuemiea S, Timothy S, Church, et al 2008. Body mass index as a predictor of Hypertension incidence among initially healthy normotensive women: American Journal of Hypertension, 10:1038.
15. Tunon J, Martin Ventura JL, Blano Colio LM, Tarin N, Egido J, 2007. Common pathways of hypercholesterolemia and Hypertension leading to atherothrombosis: The need for a global approach in the management of cardiovascular risk factors. Vascular Health Risk Management, 3(4): 521-526.
16. Whitworth JA, Kaplan N, Mendis S, Poulter N, 2003. World Health Organizatio (WHO)/International Society of Hypertension (ISH) Statement on management of hypertension. Journal of Hypertension, 21(11): 1983-1992.